Spots Global Cancer Trial Database for pexastimogene devacirepvec (pexa vec)
Every month we try and update this database with for pexastimogene devacirepvec (pexa vec) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Trial to Evaluate the Safety and Efficacy of the Combination of the Oncolytic Immunotherapy Pexa-Vec With the PD-1 Receptor Blocking Antibody Nivolumab in the First-line Treatment of Advanced Hepatocellular Carcinoma (HCC) | NCT03071094 | Hepatocellular ... | Pexastimogene D... Nivolumab | 18 Years - | Transgene | |
A Trial to Evaluate the Safety and Efficacy of the Combination of the Oncolytic Immunotherapy Pexa-Vec With the PD-1 Receptor Blocking Antibody Nivolumab in the First-line Treatment of Advanced Hepatocellular Carcinoma (HCC) | NCT03071094 | Hepatocellular ... | Pexastimogene D... Nivolumab | 18 Years - | Transgene |